{"id":"https://openalex.org/W1968501691","doi":"https://doi.org/10.1002/ijc.1364","title":"Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin","display_name":"Selective tumor sensitization to taxanes with the mAb-drug conjugate cBR96-doxorubicin","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W1968501691","doi":"https://doi.org/10.1002/ijc.1364","mag":"1968501691","pmid":"https://pubmed.ncbi.nlm.nih.gov/11477565"},"language":"en","primary_location":{"id":"doi:10.1002/ijc.1364","doi":"https://doi.org/10.1002/ijc.1364","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.1364","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074306959","display_name":"Alan F. Wahl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alan F. Wahl","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA, USA. awahl@seagen.com","Seattle Genetics Inc, Bothell, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA, USA. awahl@seagen.com","institution_ids":["https://openalex.org/I99319750"]},{"raw_affiliation_string":"Seattle Genetics Inc, Bothell, WA, USA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113579336","display_name":"Karen L. Donaldson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen L. Donaldson","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA, USA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077289817","display_name":"Bruce J. Mixan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce J. Mixan","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA, USA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058577237","display_name":"Pamela A. Trail","orcid":"https://orcid.org/0009-0006-2551-793X","observed_orcids":["https://orcid.org/0009-0006-2551-793X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela A. Trail","raw_affiliation_strings":["Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb Pharmaceutical Research Institute, Princeton, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050629314","display_name":"Clay B. Siegall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clay B. Siegall","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA, USA","institution_ids":["https://openalex.org/I99319750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074306959"],"corresponding_institution_ids":["https://openalex.org/I99319750"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":null,"fwci":1.799,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.817139,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"93","issue":"4","first_page":"590","last_page":"600"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.46480000019073486,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.46480000019073486,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.298799991607666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0843999981880188,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-monoclonal-antibody","display_name":"chimeric monoclonal antibody","score":0.8519999980926514},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9210000038146973},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9810000061988831},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.9369999766349792},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":1.0},{"id":"https://openalex.org/keywords/lewis-y-antigen","display_name":"Lewis Y antigen","score":0.9670000076293945},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6669999957084656},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/g2-cell-cycle-arrest","display_name":"G2 cell cycle arrest","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7760000228881836},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.6779999732971191},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tumor-sensitization","display_name":"tumor sensitization","score":0.5649999976158142}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8436222076416016},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7898159027099609},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7370272874832153},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6287785768508911},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5904566049575806},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5239572525024414},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4609130024909973},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.433349072933197},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.42398664355278015},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3440212905406952},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34108805656433105},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.32030099630355835},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2808881402015686},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2488323152065277},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.24588730931282043},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2455090880393982},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19862067699432373},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15285593271255493},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.1319037675857544},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0746866762638092},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007983","descriptor_name":"Lewis Blood Group Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007983","descriptor_name":"Lewis Blood Group Antigens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ijc.1364","doi":"https://doi.org/10.1002/ijc.1364","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.1364","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:11477565","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11477565","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W25774907","https://openalex.org/W120419404","https://openalex.org/W1478973534","https://openalex.org/W1514525963","https://openalex.org/W1549456397","https://openalex.org/W1557142436","https://openalex.org/W1569865130","https://openalex.org/W1605645272","https://openalex.org/W1832002274","https://openalex.org/W1933350662","https://openalex.org/W1947496848","https://openalex.org/W1963528972","https://openalex.org/W1981358768","https://openalex.org/W1983914017","https://openalex.org/W2000501107","https://openalex.org/W2008606045","https://openalex.org/W2023040267","https://openalex.org/W2031998353","https://openalex.org/W2040797730","https://openalex.org/W2055642315","https://openalex.org/W2055713782","https://openalex.org/W2069764898","https://openalex.org/W2074580909","https://openalex.org/W2083437069","https://openalex.org/W2088658971","https://openalex.org/W2094627540","https://openalex.org/W2108514136","https://openalex.org/W2116106398","https://openalex.org/W2117608472","https://openalex.org/W2122065657","https://openalex.org/W2131002958","https://openalex.org/W2133003338","https://openalex.org/W2135395701","https://openalex.org/W2140570135","https://openalex.org/W2143051140","https://openalex.org/W2143811153","https://openalex.org/W2158733752","https://openalex.org/W2162165917","https://openalex.org/W2169819140","https://openalex.org/W4240973635"],"related_works":["https://openalex.org/W2169819140","https://openalex.org/W2131002958","https://openalex.org/W2055642315","https://openalex.org/W1981358768","https://openalex.org/W1947496848","https://openalex.org/W2074580909","https://openalex.org/W1832002274","https://openalex.org/W2122065657","https://openalex.org/W1498145076","https://openalex.org/W2907534584"],"abstract_inverted_index":{"The":[0,140,178],"chimeric":[1],"monoclonal":[2],"antibody":[3],"cBR96":[4],"conjugated":[5],"to":[6,52,82,101,119,124,135,205],"doxorubicin":[7,37,109,215],"(cBR96-Dox)":[8],"is":[9,29],"selectively":[10],"internalized":[11],"by":[12,31,143,174,212,217],"a":[13,86,130,202],"wide":[14],"variety":[15],"of":[16,23,35,57,66,70,92,132,146,163,186,209],"human":[17,164,188],"carcinomas":[18],"expressing":[19],"an":[20],"extended":[21],"form":[22],"Lewis":[24],"Y":[25],"antigen":[26],"(Le(y)).":[27],"Endocytosis":[28],"followed":[30,216],"cleavage":[32],"and":[33,42,68,96,125,148,166],"release":[34],"free":[36],"from":[38],"the":[39,55,71,90,107,136,206],"endocytic":[40],"vesicles":[41],"subsequent":[43],"cytotoxicity.":[44],"Combination":[45],"studies":[46],"with":[47,77],"standard":[48],"anti-cancer":[49],"agents,":[50],"undertaken":[51],"further":[53],"increase":[54,88,98],"potency":[56],"this":[58],"targeted":[59,214],"therapy,":[60],"identified":[61],"significant":[62,155,182],"synergistic":[63],"anti-tumor":[64,156],"activity":[65],"cBR96-Dox":[67,78,147],"either":[69,175],"taxanes":[72],"paclitaxel":[73,83,149],"or":[74,183],"docetaxel.":[75],"Treatment":[76],"24":[79],"hr":[80],"prior":[81],"resulted":[84],"in":[85,89,99,127,150,154,158],"steady":[87],"percentage":[91],"G(2)":[93],"tumor":[94,190],"cells":[95,117],"corresponding":[97],"sensitivity":[100,134],"taxanes.":[102],"Cell":[103],"cycle":[104],"analysis":[105],"indicated":[106],"cBR96-delivered":[108],"was":[110,152],"most":[111],"effective":[112],"against":[113,160],"S-phase":[114],"cells,":[115],"yet":[116],"exposed":[118],"even":[120],"subtoxic":[121],"levels":[122],"progressed":[123],"arrested":[126],"G(2),":[128],"at":[129],"point":[131],"high":[133],"anti-tubulin":[137],"agent":[138,176],"paclitaxel.":[139],"synergy":[141],"obtained":[142],"staged":[144,179],"combination":[145,180],"vitro":[151],"reflected":[153],"efficacy":[157],"vivo":[159],"xenograft":[161],"models":[162],"lung":[165],"breast":[167],"tumors":[168,211],"that":[169],"could":[170],"not":[171],"be":[172],"achieved":[173],"alone.":[177],"elicited":[181],"complete":[184],"regressions":[185],"established":[187],"Le(y)-positive":[189,210],"xenografts":[191],"using":[192,213],"significantly":[193],"reduced":[194],"drug":[195],"levels.":[196],"Taken":[197],"together,":[198],"these":[199],"data":[200],"demonstrate":[201],"mechanistic":[203],"approach":[204],"selective":[207],"elimination":[208],"taxane":[218],"treatment.":[219]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}